Does intensive phototherapy produce hemolysis in newborns of 35 or more weeks gestation?

M J Maisels1, E A Kring

  • 1Department of Pediatrics, William Beaumont Hospital, Royal Oak, MI 48073, USA. jmaisels@beaumont.edu

Insights

Intensive phototherapy for newborns did not cause hemolysis, a type of red blood cell breakdown. This study monitored end-tidal carbon monoxide (ETCOc) levels in infants to assess red blood cell breakdown during treatment.

Area of Science:

  • Neonatal medicine
  • Pediatric phototherapy research
  • Hematology in newborns

Background:

  • Standard phototherapy has shown potential for causing hemolysis in infants.
  • Understanding the effects of intensive phototherapy on red blood cells is crucial for neonatal care.

Purpose of the Study:

  • To investigate whether intensive phototherapy induces hemolysis in newborn infants.
  • To assess the safety of intensive phototherapy in term and near-term infants.

Main Methods:

  • The study involved 27 newborn infants (gestational age >= 35 weeks).
  • End-tidal carbon monoxide (ETCOc) levels were measured to assess hemolysis.
  • Infants received intensive phototherapy with an average irradiance of 43 microW/cm2/nm.

Main Results:

  • A consistent decline in mean ETCOc was observed throughout the phototherapy period.
  • This decrease in ETCOc suggests no significant hemolysis occurred.

Conclusions:

  • Intensive phototherapy is not associated with hemolysis in newborn infants of 35 weeks gestation or greater.
  • The findings support the safety of intensive phototherapy for treating neonatal jaundice in this population.
Abstract

Related Concept Videos